Showing results (91-100 of 492) with videos related to
Sort By:
Pageof 50
Seminars in Liver Disease|July 30, 2020
Simplification of Care for Chronic Hepatitis C Virus InfectionJean-Michel Pawlotsky, Christian B Ramers, John F Dillon, et al.Hepatology (Baltimore, Md.)|July 31, 2008
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitisConor O'Brien, Supriya Joshi, Jordan J Feld, et al.CMAJ Open|April 13, 2017
Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysisWilliam W L Wong, Karen M Lee, Sumeet Singh, et al.Hepatology (Baltimore, Md.)|June 15, 2005
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcomeJordan J Feld, Huong Dinh, Tamara Arenovich, et al.Plos One|January 24, 2018
Population-based estimate of hepatitis C virus prevalence in Ontario, CanadaShelly Bolotin, Jordan J Feld, Gary Garber, et al.Plos One|April 16, 2015
Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screeningAlissa Visram, Kelvin K W Chan, Phyllis McGee, et al.Virus Research|March 20, 2025
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoVVahid Rajabali Zadeh, Jocelyne M Lew, M Atif Zahoor, et al.Lancet Regional Health. Americas|June 30, 2023
Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort studyBernadette Lettner, Kate Mason, Zoë R Greenwald, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2016
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infectionJordan J Feld, Ira M Jacobson, Mark S Sulkowski, et al.Clinical and Molecular Hepatology|March 18, 2026
SEVERE HEPATITIS B FLARE AND LIVER FAILURE - CURRENT ASSESSMENT AND MANAGEMENTSeng Gee Lim, Maria Buti, Jordan J Feld, et al.Pageof 50